Literature DB >> 33353777

A novel treatment strategy using continuous local antibiotic perfusion: A case series study of a refractory infection caused by hypervirulent Klebsiella pneumoniae.

Daisuke Himeno1, Yusuke Matsuura2, Akihiro Maruo3, Seiji Ohtori2.   

Abstract

BACKGROUND: Conventional topical antimicrobial therapy cannot maintain a constant local concentration, resulting in uncontrolled infection and complications. We propose continuous local antibiotic perfusion (CLAP), which can maintain a constant appropriate local antibiotic concentration for a long time with less invasiveness and complications. CLAP is clearly different from traditional treatment because it uses negative pressure to direct the continuously infused antibiotic solution to the center of infection and excrete it outside the body. This study aimed to demonstrate the effectiveness of CLAP by presenting cases in which even refractory bone and soft-tissue infections caused by the hypervirulent Klebsiella pneumoniae (hvKp) could be cured without significant tissue loss and dysfunction.
METHODS: This study is a case series in which four patients with limb infection due to hvKp were treated by CLAP. hvKp was defined by a positive string test. The therapy included intra-soft-tissue antibiotic perfusion and intramedullary antibiotic perfusion. Gentamicin (60 mg/50 cc) was infused continuously through dual-lumen tubes and bone marrow needles at low-flow rates (2 mL/h). Negative pressure was used to collect the antimicrobial solution and eliminate the dead space.
RESULTS: The infection was controlled in all four patients after a mean period of 44.3 days. The mean maximum blood concentration of gentamicin was 1.6 μg/dL, and no cases of renal dysfunction or ototoxicity occurred. After CLAP, wound closure was required in two patients and iliac bone grafting was required in one patient. As sequelae, there were one case of osteoarthritis and one case of higher brain dysfunction due to hypoxia.
CONCLUSIONS: Our results suggest that intractable hvKp infections can be controlled by CLAP. CLAP may give us the option to directly control local infections with less systemic complications. Therefore, it is considered a valuable treatment for further basic and clinical research, and this research report may be a first step.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33353777     DOI: 10.1016/j.jos.2020.11.010

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Molecular Epidemiology of Hypervirulent K. pneumoniae and Problems of Health-Care Associated Infections.

Authors:  A V Tutelyan; D S Shlykova; Sh L Voskanyan; A M Gaponov; V M Pisarev
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.737

2.  Continuous Local Antibiotics Perfusion Therapy for Acute Deep Infections after Open Fractures.

Authors:  Shunsuke Takahara; Akihiro Maruo; Hiroyuki Takayama; Toshihiko Harada
Journal:  Case Rep Orthop       Date:  2022-01-18

3.  Treatment of Chronic Osteomyelitis of the Femur by Intramedullary Antibiotic Perfusion (iMAP): A Case Report.

Authors:  Keisuke Oe; Akihiro Maruo; Tomoaki Fukui; Hirotsugu Muratsu; Ryosuke Kuroda; Takahiro Niikura
Journal:  J Orthop Case Rep       Date:  2021-12

4.  Successful treatment of acute respiratory distress syndrome caused by hypervirulent Klebsiella pneumoniae with extracorporeal membrane oxygenation and continuous renal replacement therapy: A case report and literature review.

Authors:  Wenzhong Peng; Yanhao Wu; Rongli Lu; Yunpeng Zheng; Jie Chen; Pinhua Pan
Journal:  Front Med (Lausanne)       Date:  2022-08-24

5.  Potential of Continuous Local Antibiotic Perfusion Therapy for Fracture-Related Infections.

Authors:  Kenji Kosugi; Yukichi Zenke; Naohito Sato; Daishi Hamada; Kohei Ando; Yasuaki Okada; Yoshiaki Yamanaka; Akinori Sakai
Journal:  Infect Dis Ther       Date:  2022-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.